Neuroendocrine tumors can originate almost everywhere in the body and consist of a great
variety of subtypes. This paper focuses on molecular imaging methods using nuclear …

Neuroendocrine tumors (NET) are a heterogeneous group of tumors that arise from
neuroendocrine cells. These tumors may arise from various organs, including lung, thymus …

A major focus of current drug research is to improve drug targeting to internal target sites
such as to solid tumors or specific organs. The objective of drug targeting, especially for …

Purpose The medical treatment of metastatic medullary thyroid carcinoma (MTC) is still
questionable. The aim of this study was to evaluate a combined imaging protocol using 111 …

Dimercaptosuccinic acid (DMSA) is an analog of dimercaprol used as metal chelating
moiety in variety of conditions. In nuclear medicine itself two types of Tc-99m DMSA …

BACKGROUND Medullary thyroid carcinoma (MTC) belongs in the group of neuroendocrine
tumors with early lymphatic and hepatic dissemination. A high rate of undetectable …

The aim of this study is to label CCK-8 with Tc-99m and to investigate its
radiopharmaceutical potential. CCK-8 was labeled with Tc-99m using GH and DTPA as …

Radiolabeled peptides have become important tools in nuclear oncology, both as
diagnostics and more recently also as therapeutics. They represent a distinct sector of the …

Somatostatin and its receptors are expressed in the thyroid gland, but somatostatin analogs
which are currently available have provided contradictory results in the diagnosis and …

Introduction: Medullary thyroid carcinoma (MTC) is a rare thyroid cancer secreting calcitonin
(CT) which is the most sensitive and specific tumor marker for MTC. This type of thyroid …